Rituximab therapy effective for ANCA-associated vasculitis – Phys.Org
Rituximab therapy effective for ANCA-associated vasculitisPhys.OrgIn an article published today in the New England Journal of Medicine, Immune Tolerance Network (ITN) researchers demonstrated that a single course of rituximab therapy (anti-CD20; Rituxa…
